MindImmune Therapeutics highlights the need for models for higher education to keep up with modern society and technology.
Public source
Publisher name
Public post
Models for higher Ed need to keep up with modern society and technology! Polymath University
Company
MindImmune Therapeutics
A New Approach to Neurodegeneration
- Location
- Providence, RI, US
- Company size
- 11–50 employees
About MindImmune Therapeutics
MindImmune is a biopharmaceutical company targeting the inflammatory drivers of Alzheimer's Disease and other neurodegenerative disorders. MindImmune scientists are at the forefront in recognizing the therapeutic opportunities in modulating the immune system to treat brain disease.
See moreDiscover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
MomentMD
MomentMD published an article in which it describes how medical students, PA students, and nursing students are placed in a virtual room following their own passion.
Research & Knowledge
The Picower Institute for Learning and Memory
The Picower Institute for Learning and Memory published a new atlas of the striatum revealing insights into populations of neurons affected by Huntington’s disease, schizophrenia, and addiction.
Research & Knowledge
CU Anschutz | Innovations
CU Anschutz | Innovations published a video on continued progress on neurological research from University of Colorado Anschutz, featuring Dr. Christy Niemeyer and Dr. Andrew Bubak.
Research & Knowledge
College and University Healthcare Education Consortium
College and University Healthcare Education Consortium addresses the issue of failing accreditation requirements for clinical placements in healthcare education by providing preceptor resources in coordination with leading universities.
Research & Knowledge
Education Design Lab